
Keywords: DME; diabetic macular edema; DR; diabetic retinopathy; FP; family physician; ICER; incremental cost-effectiveness ratio; NPDR; nonproliferative diabetic retinopathy; PDR; proliferative diabetic retinopathy; QALY; quality-adjusted life-year; SiDRP; Singapo